🇺🇸 FDA
Patent

US 10906871

Processes for making, and methods of using, glycopyrronium compounds

granted A61PA61P17/00A61P25/02

Quick answer

US patent 10906871 (Processes for making, and methods of using, glycopyrronium compounds) held by Dermira, Inc. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dermira, Inc.
Grant date
Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61P, A61P17/00, A61P25/02, A61P43/00